Retrieve available abstracts of 2 articles: HTML format
Single Articles
January 2024
WEBER JS, Carlino MS, Khattak A, Meniawy T, et al Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus
pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase
2b study.
Lancet. 2024 Jan 18:S0140-6736(23)02268-7. doi: 10.1016/S0140-6736(23)02268. PubMedAbstract available
July 2023
LONG GV, Swetter SM, Menzies AM, Gershenwald JE, et al Cutaneous melanoma.
Lancet. 2023 Jul 24:S0140-6736(23)00821-8. doi: 10.1016/S0140-6736(23)00821. PubMedAbstract available